ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | A087003 | HIKMA PHARMACEUTICALS USA INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Nostrum Laboratories, Inc. FDA-2025-P-0410 · 5 docket documents Nostrum Laboratories, Inc. filed this citizen petition under 21 CFR 10.25(a) and 10.30 requesting that the FDA determine whether Roxicet (Oxycodone Hydrochloride and Acetaminophen) Tablets, 5 mg/325 mg (PANDA #087003), owned by Hikma Pharmaceuticals USA Inc., was voluntarily withdrawn from sale for | 505(q) | 2025-02-06 | Granted | Nostrum Laboratories, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.